我院2003～2008年循环系统药物致215例药品不良反应报告分析

Cardiovascular Drugs-induced ADR of Our Hospital during 2003～2008: An Analysis of 215 Cases

目的:了解我院循环系统药物致药品不良反应(ADR)发生的情况,为其临床应用和ADR监测提供参考。方法:对我院2003～2008年通过电子呈报系统上报的215例涉及循环系统药物致ADR的报告进行分类统计和分析评价。结果:ADR涉及的药品共有84种,其中肾上腺素能类药ADR报告例数最多(78例),其次是钙拮抗药及抗凝血、抗血栓药和血管紧张素Ⅱ受体抑制剂等。中药引起ADR18例,涉及9种中成药;ADR报告涉及最高的3种药品是丁咯地尔、氨氯地平、前列地尔。主要的ADR临床表现为皮肤及其附件、神经及精神系统、心血管系统和消化系统损害。结论:关注此类慢性病长期用药的安全性,应继续加强对循环系统药物致ADR的监测。

OBJECTIVE： To probe into the status quo of cardiovascular drug-induced ADR and to provide reference for clinical utilization and ADR monitoring. METHODS： A total of 215 ADR cases of our hospital during 2003~2008 collected from electronic reporting system were classified, analyzed and evaluated. RESULTS： 84 kinds of drugs were involved, of which adrenergic agent occupied the dominant place （n=78）, followed by calcium antagonists, anticoagulant, fibrinolytic agents and AT1R bloker. 18 cases induced by TCM involved 9 kind of Chinese patent drug. The first 3 drugs that involved in term of frequency of ADR were buflomedil, amlodipine and alprostadil. The main clinic manifestations of ADRs were lesion of skin and its appendants, psychological system and digestive system. CONCLUSION： More attention should be paid to safety of long-term prescription in such chronic disease and cardiovascular drug-induced ADR monitoring.